(Q38573611)

4 September 2017

1 reference

title

Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions (English)

1 reference

4 September 2017

P R Finley

1

1 reference

PubMed ID

7696728

4 September 2017

language of work or name

English

0 references

publication date

1 December 1994

1 reference

Annals of Pharmacotherapy

4 September 2017

1 reference

4 September 2017

28

1 reference

4 September 2017

1359-1369

1 reference

4 September 2017

12

1 reference

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

4 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Review of the animal pharmacology and pharmacokinetics of fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

The tolerance and antidepressive activity of fluvoxamine as a single dose compared to a twice daily dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

A double-blind controlled clinical trial comparing fluvoxamine with imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Treatment of fibrositis with fluoxetine hydrochloride (Prozac).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Fluoxetine treatment of severe premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Fluoxetine: a serotonin-specific, second-generation antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Fluoxetine, fluvoxamine and extrapyramidal tract disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Emergence of intense suicidal preoccupation during fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Interaction between carbamazepine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

The effect of fluoxetine on warfarin metabolism in the rat and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

The pharmacokinetics of paroxetine in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402801207

Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1097/00007691-199212000-00010

Identifiers

DOI

10.1177/106002809402801207

1 reference

4 September 2017

1 reference

PubMed ID

7696728